REFERENCES
- Sanchez A, Alonso MJ. Nanoparticular carriers for ocular drug delivery. In: Torchilin V (Ed.). Nanoparticulates as Drug Carriers. London, UK: World Scientific-Imperial College Press, 2006.
- Hay DNT, Rickert PG, Seifert S, et al. Thermoresponsive nanostructures by self-assembly of a poly (N isopropylacrylamide)- lipid conjugate. J Am Chem Soc. 2004;126:2290–2291.
- Kakizawa Y, Kataoka K. Block copolymer self-assembly into monodispersive nanoparticles with hybrid core of antisense DNA and calcium phosphate. Langmuir. 2002;18:4539–4543.
- Topp MDC, Dijkstra PJ, Talsma H, et al. Thermosensitive micelle-forming block copolymers of poly (ethylene glycol) and poly (N-isopropylacrylamide). Macromolecules. 1997;30:8518–8520.
- Chaw CS, Chooi KW, Liu XM, et al. Thermally responsive core–shell nanoparticles self-assembled from cholesteryl end-capped and grafted polyacrylamides: Drug incorporation and in vitro release. Biomaterials. 2004;25:4297–4308.
- Chung JE, Yokoyama M, Okano T. Inner core segment design for drug delivery control of thermo-responsive polymeric micelles. J. Control Rel. 2000;65:93–103.
- Hamidi M, Azadi A, Rafiei P. Hydrogel nanoparticles in drug delivery. Adv Drug Delivery Rev. 2008;60:1638–1649.
- Sahoo SK, Labhasetwar V. Nanotech approaches to drug delivery and imaging. Drug Dis Today 2003;8:1112–1120.
- Sahoo SK, Dilnawaz F, Krishnakumar S. Nanotechnology in ocular drug delivery. Drug Discov Today. 2008;13:144–150.
- Gupta AK, Madan S, Majumdar DK, et al. Ketorolac entrapped in polymeric micelles: Preparation, characterisation and ocular anti-inflammatory studies. Int J Pharm. 2000;209:1–14.
- Maitra AN, Gupta AK, Majumdar D, et al. Sustained release and long residing ophthalmic formulation and the process of preparing the same. U.S. Patent 0064513 A1, May 30, 2002.
- Maitra AN, Gupta AK, Majumdar D, et al. Sustained release and long residing ophthalmic formulation and the process of preparing the same. U.S. Patent 6579519 B2, June 17, 2003.
- Kassem MA, Abdel Rahman AA, Ghorab MM, et al. Nanosuspension as an ophthalmic delivery system for certain glucocorticoid drugs. Int J Pharm. 2007;340:126–133.
- Lang JC. Ocular drug delivery conventional ocular formulations. Adv Drug Deliv Rev. 1995;16:39–43.
- Nagarwal RC, Kant S, Singh PN, et al. Polymeric nanoparticulate system: A potential approach for ocular drug delivery. J Control Rel. 2009;136:2–13.
- De Jaeghere F, Doelker E, Gurny R. In: Mathiowitz E (Ed). Nanoparticles. Encyclopedia of Controlled Drug Delivery. New York: John Wiley & Sons, Inc.,1999;2:641–664.
- Veiseh M, Gunn JW, Zhang M. Design and fabrication of magnetic for targeted drug delivery and imaging. 2009; in press.
- Hogan MJ, Kimura ST, Thygeson P. Signs and symptoms of uveitis. Archives of Ophthalmology. 1959 May; 47(5, Part 2):155–170.
- Urtti A, Salminen L. Animal pharmacokinetic studies. In: Mitra AK (Ed.). Ophthalmic Drug Delivery Systems. New York: Marcel Dekker, 1993; pp. 121–136.
- Hornof M, Toropainen E, Urtti A. Cell culture models of the ocular barriers. Eur J Pharm Biopharm. 2005;60:207–225.
- Michelle L, Reichle OD. Complications of intravitreal steroid injections. J Am Optom Assoc. 2005; 76: 450–460.